Tetraphase has developed a robust antibiotics platform based on the tetracycline core, which offers the potential to dramatically improve the treatment of both broad and selective spectrum bacterial infections.
Tetraphase Pharmaceuticals
![Tetraphase Pharmaceuticals](http://baycitycapital.com/wp-content/uploads/2014/10/portfolio-tetraphase.jpg)
Tetraphase has developed a robust antibiotics platform based on the tetracycline core, which offers the potential to dramatically improve the treatment of both broad and selective spectrum bacterial infections.